GlassScriptPhysician profile
John T Pattison
NPI 1851860332
$813.49
in general payments reported to CMS, 2019-2025
16 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $91.45 · 2023: $90.66 · 2024: $164 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $255.64 | 2023-2025 | Spravato, Invega Sustenna |
| Axsome Therapeutics, INC. | $104.53 | 2024-2025 | Auvelity |
| Braeburn INC. | $79.31 | 2023-2025 | Brixadi |
| Abbvie INC. | $77.63 | 2021-2024 | |
| Novo Nordisk INC | $52.29 | 2024-2025 | |
| Exact Sciences Corporation | $33.95 | 2025 | The Cologuard Plus Collection Kit |
| Alkermes, INC. | $32.02 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $26.05 | 2023 | Rexulti |
| Neurocrine Biosciences, INC. | $24.56 | 2024 | Ingrezza |
| Biomerieux INC | $22.00 | 2025 | Biofire Spotfire Control Station |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.48 | 2023 | Xifaxan |
| Eisai INC. | $18.65 | 2025 | |
| Pfizer INC. | $18.27 | 2025 | |
| Bioventus LLC | $18.06 | 2025 | Durolane |
| Insulet Corporation | $17.79 | 2025 | Omnipod |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visby Medical, INC. | $13.26 | 2025 | Visby Medical Sexual Health Click Test |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pattison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.